On July 28, 2025, Envoy Medical, Inc. amended its Shortfall Warrants, changing the exercise price based on a weekly volume-weighted average price, with a minimum of $1.50 per share. This filing is related to previously issued warrants under an equity agreement with Meteora Parties.